Jake P. Mann

ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta‐analysis

Estimated birth prevalence of Menkes disease and ATP7A-related disorders based on the Genome Aggregation Database (gnomAD)

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease

Autoimmune hepatitis

Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis

Burden of liver diseases in the world

Infants Born with Down Syndrome: Burden of Disease in the Early Neonatal Period

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

Hepatocellular carcinoma

Non-alcoholic fatty liver disease

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Adaptive immunity: an emerging player in the progression of NAFLD

Cutting edge issues in autoimmune hepatitis

Mechanisms of insulin resistance related to white, beige, and brown adipocytes

Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

CADD: predicting the deleteriousness of variants throughout the human genome

Down Syndrome

Tirzepatide Once Weekly for the Treatment of Obesity

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity

Pathophysiology of Type 2 Diabetes Mellitus

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis

The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non‐alcoholic fatty liver disease: A randomized controlled trial

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD

Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review

The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD

Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management

The global prevalence of Wilson disease from next-generation sequencing data

Systematic Review of Definitions of Failure in Revisional Bariatric Surgery

Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy

Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease

Management and outcomes of neonates with down syndrome admitted to neonatal units

Nonalcoholic Fatty Liver Disease in Children

What lipodystrophies teach us about the metabolic syndrome

Insights into genetic variants associated with NASH-fibrosis from metabolite profiling